Nuvation Bio
NUVB
NUVB
124 hedge funds and large institutions have $490M invested in Nuvation Bio in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
5% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 39
0.07% more ownership
Funds ownership: 61.69% → 61.75% (+0.07%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
124
Holding in Top 10
3
Calls
$226K
Puts
$11K
Top Buyers
| 1 | +$5.85M | |
| 2 | +$4.86M | |
| 3 | +$4.18M | |
| 4 |
Barclays
London,
United Kingdom
|
+$4.07M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$2.81M |
Top Sellers
| 1 | -$7.97M | |
| 2 | -$6.55M | |
| 3 | -$3.64M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.19M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.15M |